Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Marc Lehmann"'
Autor:
Philipp Ernst, Adrian T. Press, Mike Fischer, Vivien Günther, Christine Gräfe, Joachim H. Clement, Thomas Ernst, Ulrich S. Schubert, Jana Wotschadlo, Marc Lehmann, Christoph Enzensperger, Michael Bauer, Andreas Hochhaus
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss , Pp 372-381 (2020)
In chronic myelogenous leukemia (CML), treatment with tyrosine kinase inhibitors (TKI) is unable to eradicate leukemic stem cells (LSC). Polymethine dye-functionalized nanoparticles can be internalized by specific cell types using transmembrane carri
Externí odkaz:
https://doaj.org/article/67947521e5e3418a85f1055be7115221
Autor:
Kira von Bernuth, Peter Seidel, Julia Krebs, Marc Lehmann, Britta Neumann, Norbert Konrad, Annette Opitz-Welke
Publikováno v:
Frontiers in Psychiatry, Vol 11 (2020)
BackgroundAmong people living in detention, substance use is highly prevalent, including opioid dependence. Opioid agonist treatment (OAT) has been established as an evidence-based, first-line treatment for opioid dependence. Despite high prevalence
Externí odkaz:
https://doaj.org/article/0abf577d63104df9a15970cb014d4241
Publikováno v:
BMC Public Health, Vol 17, Iss 1, Pp 1-14 (2017)
Abstract Background In Germany, medical care of prisoners is completely separated from extramural health care. The extent and quality of medical care among prisoners in Germany are therefore largely unknown. We performed a secondary data analysis of
Externí odkaz:
https://doaj.org/article/18b5436573ee473fb88afb2616894e34
Autor:
Blerina Shkodra, Adrian T. Press, Antje Vollrath, Ivo Nischang, Stephanie Schubert, Stephanie Hoeppener, Dorothee Haas, Christoph Enzensperger, Marc Lehmann, Petra Babic, Kay Jovana Benecke, Anja Traeger, Michael Bauer, Ulrich S. Schubert
Publikováno v:
Pharmaceutics, Vol 12, Iss 11, p 1110 (2020)
Bisindolylmaleimide I (BIM-I) is a competitive pan protein kinase C inhibitor with anti-inflammatory and anti-metastatic properties, suggested to treat inflammatory diseases and various cancer entities. However, despite its therapeutic potential, BIM
Externí odkaz:
https://doaj.org/article/239eaf11ef024de1bc10c5624c3ffef9
Autor:
Frank Bloos, Svea Sachse, Andreas Kortgen, Mathias W Pletz, Marc Lehmann, Eberhard Straube, Niels C Riedemann, Konrad Reinhart, Michael Bauer
Publikováno v:
PLoS ONE, Vol 7, Iss 9, p e46003 (2012)
BACKGROUND: Treatment of septic shock relies on appropriate antimicrobial therapy. Current culture based methods deliver final results after days, which may delay potentially lifesaving adjustments in antimicrobial therapy. This study was undertaken
Externí odkaz:
https://doaj.org/article/8e39763cfd0044438478b85ed8cc72c9
Autor:
Marc Lehmann, Robin Walborn
Publikováno v:
Edition Forschung und Entwicklung in der Strafrechtspflege ISBN: 9783658360450
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4de11ca7473117e7fc38eb66adcbd91c
https://doi.org/10.1007/978-3-658-36046-7_17
https://doi.org/10.1007/978-3-658-36046-7_17
Publikováno v:
Day 1 Mon, October 17, 2022.
The oil-in-water (OiW) contaminants in produced water discharges arising from offshore oil and gas production systems are required by global regulatory bodies to be monitored in order to limit the environmental impacts of such releases. The level of
Autor:
Marc Lehmann, Katerina Lepkova, Thunyaluk Pojtanabuntoeng, Varun Ghodkay, Annamaria Greenwood, Susumu Hirano, Toshiyuki Sunaba
Publikováno v:
Day 2 Wed, March 23, 2022.
Monoethylene glycol (MEG) is often used to reduce the differential pressure across well valves so that they can be opened without damage. This MEG ultimately commingles with production fluids and if not deoxygenated contributes to the overall content
Publikováno v:
Day 2 Wed, March 23, 2022.
When monoethylene glycol (MEG) is used to provide hydrate protection for gas condensate production, MEG pre-treatment, reconcentration and reclamation systems are generally employed to recover and reuse the MEG. Prior to reconcentration, low solubili
Autor:
Ulrich S. Schubert, Michael Bauer, Thomas Ernst, Jana Wotschadlo, Adrian T. Press, Marc Lehmann, Michael Fischer, Andreas Hochhaus, Christoph Enzensperger, Vivien Günther, Joachim H. Clement, Philipp Ernst, Christine Gräfe
Publikováno v:
Molecular Therapy: Oncolytics, Vol 18, Iss, Pp 372-381 (2020)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
In chronic myelogenous leukemia (CML), treatment with tyrosine kinase inhibitors (TKI) is unable to eradicate leukemic stem cells (LSC). Polymethine dye-functionalized nanoparticles can be internalized by specific cell types using transmembrane carri